Clinical Trial Update: A Study of the Pharmacokinetics of ER OROS Paliperidone in Volunteers With Normal or Impaired Renal Function [Phase 1]

View source ↗

Summary

This Phase 1 pharmacokinetic study evaluates ER OROS Paliperidone in volunteers with normal and impaired renal function to understand the impact of kidney funct…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ER OROS Paliperidone (paliperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Schizophrenia, Renal Impairment | Phase 1 | Status: COMPLETED